TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nasalprodukter Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
961
|
933
|
746 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
2,502
|
1,855
|
2,223 |
| EBITDA |
2,508
|
1,856
|
2,245 |
| Total assets |
12,451
|
11,840
|
9,098 |
| Current assets |
12,231
|
11,609
|
8,860 |
| Current liabilities |
4,706
|
4,136
|
2,927 |
| Equity capital |
7,341
|
7,230
|
5,755 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
59.0%
|
61.1%
|
63.3% |
| Turnover per employee |
961
|
933
|
746 |
| Profit as a percentage of turnover |
260.4%
|
198.8%
|
298.0% |
| Return on assets (ROA) |
20.1%
|
15.7%
|
24.4% |
| Current ratio |
259.9%
|
280.7%
|
302.7% |
| Return on equity (ROE) |
34.1%
|
25.7%
|
38.6% |
| Change turnover |
60
|
185
|
-301 |
| Change turnover % |
7%
|
25%
|
-29% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.